Several analysts have recently updated their ratings and price targets for Analog Devices (NASDAQ: ADI): 1/17/2026 – Analog Devices was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating. 1/16/2026 – Analog Devices had its “overweight” rating reaffirmed by analysts at Morgan Stanley. They now have a $314.00 price […]

Several analysts have recently updated their ratings and price targets for Landstar System (NASDAQ: LSTR): 1/15/2026 – Landstar System had its price target raised by analysts at Barclays PLC from $130.00 to $155.00. They now have an “equal weight” rating on the stock. 1/15/2026 – Landstar System had its price target raised by analysts at […]

Twilio (NYSE: TWLO) recently received a number of ratings updates from brokerages and research firms: 1/15/2026 – Twilio had its price target raised by analysts at Morgan Stanley from $154.00 to $169.00. They now have an “overweight” rating on the stock. 1/7/2026 – Twilio had its price target raised by analysts at Rosenblatt Securities from […]

Lemonade (NYSE: LMND) recently received a number of ratings updates from brokerages and research firms: 1/16/2026 – Lemonade had its “outperform” rating reaffirmed by analysts at Citigroup Inc.. 1/14/2026 – Lemonade had its price target raised by analysts at Cantor Fitzgerald from $85.00 to $92.00. They now have an “overweight” rating on the stock. 1/6/2026 […]

Synaptics (NASDAQ: SYNA) recently received a number of ratings updates from brokerages and research firms: 1/15/2026 – Synaptics had its “overweight” rating reaffirmed by analysts at Barclays PLC. They now have a $100.00 price target on the stock. 1/15/2026 – Synaptics had its price target raised by analysts at Wells Fargo & Company from $95.00 […]

Oruka Therapeutics (NASDAQ: ORKA) recently received a number of ratings updates from brokerages and research firms: 1/13/2026 – Oruka Therapeutics had its price target raised by analysts at Wedbush from $42.00 to $45.00. They now have an “outperform” rating on the stock. 1/12/2026 – Oruka Therapeutics had its price target raised by analysts at BTIG […]

Houlihan Lokey (NYSE: HLI) recently received a number of ratings updates from brokerages and research firms: 1/12/2026 – Houlihan Lokey was downgraded by analysts at Weiss Ratings from a “buy (b-)” rating to a “hold (c+)” rating. 1/8/2026 – Houlihan Lokey had its price target lowered by analysts at Keefe, Bruyette & Woods from $228.00 […]

Several analysts have recently updated their ratings and price targets for MediaAlpha (NYSE: MAX): 1/11/2026 – MediaAlpha was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating. 1/3/2026 – MediaAlpha was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating. 12/31/2025 – MediaAlpha […]

Host Hotels & Resorts (NASDAQ: HST) has recently received a number of price target changes and ratings updates: 1/16/2026 – Host Hotels & Resorts was given a new $18.00 price target on by analysts at Morgan Stanley. 1/13/2026 – Host Hotels & Resorts had its “buy” rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. 1/12/2026 […]